The effect of magnesium trisilicate mixture, metoclopramide and ranitidine on gastric pH, volume and serum gastrin
- PMID: 2986474
- DOI: 10.1111/j.1365-2044.1985.tb10750.x
The effect of magnesium trisilicate mixture, metoclopramide and ranitidine on gastric pH, volume and serum gastrin
Abstract
Eighty women (40 for elective Caesarean section and 40 for elective gynaecological surgery) were randomly assigned to one of five treatment groups and received pre-operatively either no medication; magnesium trisilicate mixture (BP) 30 ml; metoclopramide 10 mg intramuscularly; ranitidine 150 mg orally on the night prior to, and the morning of, surgery; or metoclopramide 10 mg intramuscularly in combination with oral ranitidine 150 mg (the latter again given on the night prior, and the morning, of surgery). The effect of these medications on intragastric pH, volume and serum gastrin-17 was measured. No patient receiving ranitidine had a pH of less than 4. Magnesium trisilicate mixture resulted in the largest intragastric pH change although one woman in this group had a pH of 1.7. The largest intragastric volumes were seen in the patients who had received magnesium trisilicate mixture, whilst the patients who had received metoclopramide in combination with ranitidine had the smallest intragastric volumes. Magnesium trisilicate mixture and metoclopramide resulted in no change in serum gastrin levels. However, in the subjects who had received ranitidine on the night prior to surgery, the fasting serum gastrin was significantly higher (p less than 0.01) than the values in the remaining subjects, the mean (SEM) values being 60.3 (6.3) pg/ml in those not receiving ranitidine and 111.3 (19.5) pg/ml in those who had been given ranitidine.
Similar articles
-
Comparison of the prophylactic use of magnesium trisilicate mixture B.P.C., sodium citrate mixture or cimetidine in obstetrics.Br J Anaesth. 1984 Apr;56(4):355-62. doi: 10.1093/bja/56.4.355. Br J Anaesth. 1984. PMID: 6324832 Clinical Trial.
-
Magnesium trisilicate mixture BP. Its physical characteristics and effectiveness as a prophylactic.Anaesthesia. 1984 Jun;39(6):535-9. doi: 10.1111/j.1365-2044.1984.tb07356.x. Anaesthesia. 1984. PMID: 6331217
-
Oral ranitidine in labour.Anaesthesia. 1984 May;39(5):433-8. doi: 10.1111/j.1365-2044.1984.tb07311.x. Anaesthesia. 1984. PMID: 6329021 Clinical Trial.
-
Prophylaxis for aspiration pneumonitis.Can Anaesth Soc J. 1986 May;33(3 Pt 2):S47-53. doi: 10.1007/BF03019156. Can Anaesth Soc J. 1986. PMID: 2872952 Review. No abstract available.
-
Control of intragastric pH and volume.Br J Anaesth. 1984 Jan;56(1):47-57. doi: 10.1093/bja/56.1.47. Br J Anaesth. 1984. PMID: 6140932 Review. No abstract available.
Cited by
-
Interventions at caesarean section for reducing the risk of aspiration pneumonitis.Cochrane Database Syst Rev. 2014 Feb 5;2014(2):CD004943. doi: 10.1002/14651858.CD004943.pub4. Cochrane Database Syst Rev. 2014. PMID: 24497372 Free PMC article.
-
Perioperative fasting and feeding in adults, obstetric, paediatric and bariatric population: Practice Guidelines from the Indian Society of Anaesthesiologists.Indian J Anaesth. 2020 Jul;64(7):556-584. doi: 10.4103/ija.IJA_735_20. Epub 2020 Jul 1. Indian J Anaesth. 2020. PMID: 32792733 Free PMC article. No abstract available.
-
Interventions at caesarean section for reducing the risk of aspiration pneumonitis.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004943. doi: 10.1002/14651858.CD004943.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2014 Feb 05;(2):CD004943. doi: 10.1002/14651858.CD004943.pub4. PMID: 20091567 Free PMC article. Updated.
-
Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007579. doi: 10.1002/14651858.CD007579.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2021 May 18;5:CD007579. doi: 10.1002/14651858.CD007579.pub3. PMID: 22972112 Free PMC article. Updated.
-
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003. Drugs. 1989. PMID: 2667937 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical